Vitamin D Receptor Agonists for Hemodialysis Patients, Titin Los-of-Function Variants and Atrial Fibrillation, COIs as Research Misconduct, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 11, 2018 issue
Source: JAMA: This Week's Audio Commentary - Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
More News: American Medical Association (AMA) | Atrial Fibrillation | Dialysis | General Medicine | Hemodialysis | Vitamin D | Vitamins